Clinical trial

Stroke in Young Fabry Patients (sifap1): Frequency of Fabry Disease in Young…

NCT00414583 · CENTOGENE GmbH Rostock, Industry · Completed

Key facts

NCT number NCT00414583
Title Stroke in Young Fabry Patients (sifap1): Frequency of Fabry Disease in Young Stroke Patients
Official title Stroke in Young Fabry Patients (sifap1): Frequency of Fabry Disease in an Unselected Group of Young Stroke Patients: an International, Multicentre Prevalence Study
Acronym sifap1
Lead sponsor CENTOGENE GmbH Rostock, Industry
Collaborators Shire Human Genetic Therapies, Inc. Industry
Status Completed
Study type Observational
Conditions Cerebrovascular Accident
Intervention type Other
Interventions No intervention
Enrollment 5,000
Start date Jan 1, 2008
Primary completion Jan 1, 2010
Completion Jan 1, 2010
First posted Dec 21, 2006
Last update posted Apr 9, 2021
Countries Austria, Belgium, Croatia, Finland, France, Georgia, Germany, Ireland, Italy, Malta, Poland, Portugal and 2 more

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies